Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
11 hedge funds and large institutions have $520K invested in Liminal BioSciences Inc. Common Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
31% less funds holding
Funds holding: 16 → 11 (-5)
84% less capital invested
Capital invested by funds: $3.21M → $520K (-$2.69M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$35.3K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$27.3K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.37M |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$170K |
| 3 |
AI
Atom Investors
Austin,
Texas
|
-$64K |
| 4 |
VF
Virtu Financial
New York
|
-$61.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FDCDDQ
1
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $208K | +$27.3K | +562 | +13% |
|
|
SFI
2
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $138K | -$170K | -3,502 | -51% |
|
|
VF
3
Virtu Financial
New York
| $93K | -$61.4K | -1,264 | -36% |
|
|
4
Morgan Stanley
New York
| $37K | +$35.3K | +727 | +469% |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $36K | +$7.18K | +148 | +21% |
|
6
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $4K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | -$49 | -1 | -7% |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $966 | – | – | – |
|
|
AC
10
Armistice Capital
New York
| – | -$2.37M | -56,524 | Closed |
|
|
AI
11
Atom Investors
Austin,
Texas
| – | -$64K | -1,512 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$51K | -1,220 | Closed |
|
13
Jane Street
New York
| – | -$48K | -1,152 | Closed |
|
|
ASN
14
Advisory Services Network
Atlanta,
Georgia
| – | -$8K | -200 | Closed |
|
15
UBS Group
Zurich,
Switzerland
| – | -$97 | -2 | -67% |
|
LMNL Hedge Fund Activity: Q1 2021 in Review
11 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q1 2021, worth a combined $520K — down 84% from $3.21M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LMNL and 0 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Morgan Stanley, adding an estimated $35.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.37M sold.
- 11 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q1 2021, down from 16 in Q4 2020.
- Funds reported $520K of Liminal BioSciences Inc. Common Shares stock for Q1 2021, down 84% quarter-over-quarter.
- 0 funds opened new Liminal BioSciences Inc. Common Shares positions in Q1 2021 and 5 closed out, a net change of -5 holders.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q1 2021 was Morgan Stanley, an estimated $35.3K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q1 2021 was Armistice Capital, an estimated $2.37M sold.
Based on aggregated 13F filings for Q1 2021.